Company profile: Mabtech
1.1 - Company Overview
Company description
- Provider of monoclonal antibodies and immunoassay kits for ELISA, ELISpot, and FluoroSpot; automated readers (Mabtech IRIS 2 for ELISpot, FluoroSpot, and FociSpot; Mabtech ASTOR 2 for ELISpot) for spot counting and data analysis; and reagents including peptide pools, polyclonal stimuli, buffers, substrates, plates, and antibodies to cytokines, immunoglobulins, and apolipoproteins.
Products and services
- ELISA Kits: Kit-based assays used to detect and quantify soluble substances such as proteins, peptides, antibodies, and hormones in ELISA workflows for analyte concentration measurement
- ELISpot Kits: Cell-based assay kits that quantify analyte secretion at the single-cell level in ELISpot, providing single-cell resolution of secreted analytes
- FluoroSpot Kits: Cell-based assay kits that detect multiple analytes simultaneously at the single-cell level in FluoroSpot, allowing concurrent identification of several secreted analytes from individual cells
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mabtech
Bioventix
HQ: United Kingdom
Website
- Description: Provider of high-affinity sheep monoclonal antibodies, specializing in their creation and supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioventix company profile →
Ion Torrent
HQ: United States
Website
- Description: Provider of sequencing technology that enables a direct connection between chemical and digital information; the first commercial PostLight sequencing technology that doesn't use light. Ion Torrent is a wholly-owned subsidiary of Life Technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ion Torrent company profile →
Remedy Plan
HQ: United States
Website
- Description: Provider of pre-clinical cancer therapeutics developing first-in-class small molecule drugs that differentiate cancer cells, including RPT1G, a clinical candidate targeting NAMPT for solid and hematological malignancies. Offers NAMPT programs in oncology, autoimmune, and obesity, and a proprietary high-throughput phenotypic drug screening platform targeting critical pathways in cancer stem cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remedy Plan company profile →
Accel Biotech
HQ: United States
Website
- Description: Provider of OEM robotic engines, liquid handling solutions, customized robotics, and components, manufacturing and distributing these offerings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accel Biotech company profile →
Perfectus Biomed
HQ: United Kingdom
Website
- Description: Provider of U.K.-based microbiological services with a research-driven approach to testing, rapid turnaround, and personalized service, specializing in bespoke assays and biofilm testing. Offers biological safety consulting, clinical research for medical devices, IVD services, product development strategy, quality and regulatory consulting, and the NAMSA APEX Program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perfectus Biomed company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mabtech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mabtech
2.2 - Growth funds investing in similar companies to Mabtech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mabtech
4.2 - Public trading comparable groups for Mabtech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →